Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/26/2026

1. DKS
2. INTU
3. ZM
4. SMTC
5. SPY
6. META
7. NCNO
8. JAZZ
9. NVDA
10. BOX

Go back to Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer
(NASDAQ: PPCB) Delayed: 1.09 -0.04 (3.54%)
Previous Close $1.13    52 Week High $ 
Open $1.12    52 Week Low $ 
Day High $1.12    P/E N/A 
Day Low $1.09    EPS $ 
Volume 5,327       

(NASDAQ: PPCB) Delayed: 1.09 -0.04 (3.54%)
Previous Close $1.13    52 Week High $ 
Open $1.12    52 Week Low $ 
Day High $1.12    P/E N/A 
Day Low $1.09    EPS $ 
Volume 5,327